First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...
Bowl of Quick Cook on MSN
A Troubling Pattern: Unpacking the Salad Recall and Persistent Food Safety Challenges Confronting Publix
Grocery shopping was once so straightforward pick up what you want and go home. But with today’s globalized food supply chain ...
Neal J. Riley is a digital producer for CBS Boston. He has been with WBZ-TV since 2014. His work has appeared in The Boston Globe and The San Francisco Chronicle. Neal is a graduate of Boston ...
The Food and Drug Administration is recalling 16 brands of cinnamon that contain elevated lead levels, which over time can cause neurological problems including learning disabilities in young children ...
Denali Therapeutics has become the latest on a growing list of biotechs to experience an FDA review delay in recent months. The agency in July accepted an application for Denali's enzyme replacement ...
Lizzy Lawrence spoke with more than 20 current and former FDA staff, interviewed legal experts, and reviewed agency documents to report this story. Lizzy Lawrence leads STAT’s coverage of the Food and ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A troubled Indiana ...
The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...
The third quarter of 2025 delivered a welcome bolus of novel FDA drug approvals, with the 16 approvals in the quarter matching the 16 approvals in total in the first half of the year (Table 1).
The FDA has approved Celltrion's Eydenzelt, a new aflibercept biosimilar, enhancing treatment options for retinal diseases in the US. The FDA has approved Eydenzelt (aflibercept-boav), an aflibercept ...
The Abbott TactiFlex Duo Sensor Enabled ablation system. [Image from Uri Yaron on LinkedIn] An Abbott (NYSE: ABT) + official posted on social media to announce FDA breakthrough device designation for ...
Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback